Detection and management of late-onset 21-hydroxylase deficiency in women with hyperandrogenism;Dépistage et prise en charge du déficit en 21-hydroxylase à révélation tardive chez les femmes avec hyperandrogénie

Annales d'Endocrinologie

Volumn 71, Issue 1, 2010, Pages

  Young, J ^a   Tardy, V ^b   Brac de la Perriere A ^c   Bachelot, A ^d   Morel, Y ^b  

^a BICÊTRE HOSPITAL   (France)

^b Hospices Civils de Lyon   (France)

^c Hopital Neuro Cardiologique   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; CYTOCHROME P450; CYTOCHROME P450 21A2; ESTROGEN; ETHINYLESTRADIOL; GLUCOCORTICOID; SYNACHTHENE; TETRACOSACTIDE; UNCLASSIFIED DRUG;

ARTICLE; CONSULTATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG INDICATION; FEMALE; FEMALE FERTILITY; GENE MUTATION; HUMAN; HYPERANDROGENISM; LABORATORY TEST; STEROID 21 MONOOXYGENASE DEFICIENCY;

EID: 76949094199     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2009.12.010     Document Type: Article

References (24)

1. New M.I. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 91 (2006) 4205-4214 Erratum in: J Clin Endocrinol Metab. 2007;92:142
2. Kuttenn F., Couillin P., Girard F., Billaud L., Vincens M., Boucekkine C., et al. Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 313 (1985) 224-231
3. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., and Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89 (2004) 2745-2749
4. Escobar-Morreale H.F., Sanchón R., and San Millán J.L. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 93 (2008) 527-533
5. Carmina E., Rosato F., Jannì A., Rizzo M., and Longo R.A. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91 (2006) 2-6
6. Moran C., Azziz R., Carmina E., Dewailly D., Fruzzetti F., Ibañez L., et al. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 183 (2000) 1468-1474
7. Speiser P.W., Knochenhauer E.S., Dewailly D., Fruzzetti F., Marcondes J.A., and Azziz R. A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. Mol Genet Metab 71 (2000) 527-534
8. Bidet M., Bellanné-Chantelot C., Galand-Portier M.B., Tardy V., Billaud L., Laborde K., et al. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 94 (2009) 1570-1578
9. Fiet J., Gueux B., Gourmelen M., Kuttenn F., Vexiau P., Couillin P., et al. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia. J Clin Endocrinol Metab 66 (1988) 659-667
10. Tardy-Guidollet V. Le déficit en 21-hydroxylase : mise au point de l'exploration moléculaire de 1538 patients et 188 hétérozygotes. Doctorat d'université Lyon I, année 2002.
11. Moreira A.C., and Elias L.L. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency. J Clin Endocrinol Metab 74 (1992) 198-203
12. Huerta R., Dewailly D., Decanter C., Knochenhauer E.S., Boots L.R., and Azziz R. Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril 74 (2000) 329-334
13. Galand-Portier MB, Kuttenn F. Hyperplasie congénitale des surrénales à révélation tardive par déficit partiel en 21-hydroxylase. EMC (Elsevier Masson SAS, Paris), Endocrinologie-Nutrition, 10-015-B-25, 2007.
14. Martin K.A., Chang R.J., Ehrmann D.A., Ibanez L., Lobo R.A., Rosenfield R.L., et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93 (2008) 1105-1120 Epub 2008 Feb 5
15. Spritzer P., Billaud L., Thalabard J.C., Birman P., Mowszowicz I., Raux-Demay M.C., et al. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab 70 (1990) 642-646
16. Frank-Raue K., Junga G., Raue F., Vecsei P., and Ziegler R. Therapy of hirsutism in females with adrenal enzyme defects of steroid hormone biosynthesis: comparison of dexamethasone with cyproterone acetate. Klin Wochenschr 68 (1990) 597-601
17. Moran C., Azziz R., Weintrob N., Witchel S.F., Rohmer V., Dewailly D., et al. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 91 (2006) 3451-3456
18. Holmes-Walker D.J., Conway G.S., Honour J.W., Rumsby G., and Jacobs H.S. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 43 (1995) 291-296
19. Feldman S., Billaud L., Thalabard J.C., Raux-Demay M.C., Mowszowicz I., Kuttenn F., et al. Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 74 (1992) 635-639
20. Morel Y., and Tardy V. Molecular genetics of 21-hydroxylase deficient adrenal hyperplasia. In: Azziz R., Nestler J.E., and Dewailly D. (Eds). Androgen excess disorders in women (1997), Lippincott-Raven 159-172
21. Tardy V., Carel J.C., Forest M.G., et al. Nonclassical forms of 21-hydroxylase deficiency revisited by molecular biology (186 patients, French collaborative studies). Horm Res 46 suppl 2 (1996) 9
22. Gourmelen M., Gueux B., Pham Huu Trung M.T., et al. Detection of heterozygous carriers for 21-hydroxylase deficiency by plasma 21-deoxycortisol measurement. Acta Endocrinol (Copenh) 116 (1987) 507-512
23. Forest M.G., Pugeat M., Monneret M.P., et al. Normative data for the response of plasma 21-deoxycortisol to ACTH stimulation: efficient screening test for heterozygocy of 21-hydroxylase deficiency in the general population. Hormone Res 41 (1994) 110
24. Forest M.G., Tardy V., Nicolino M., David M., and Morel Y. 21-Hydroxylase deficiency: an exemplary model of the contribution of molecular biology in the understanding and management of the disease. Ann Endocrinol (Paris) 66 3 (2005) 225-232 [Review]